Gilead announces positive Biktarvy data for HIV and hepatitis B
South Africa Standard Time —
Biktarvy
is a complete HIV treatment, combining three medicines to form the
smallest three-drug, single-tablet regimen (STR) available, as a
simple ...
He ceased antiretroviral therapy and was functionally cured. He became known as the Berlin Patient, and since that case there have been two more ... View article...
The researchers specifically looked at communicable diseases ( HIV and TB), and also non-communicable diseases or lifestyle diseases (hypertension, ... View article...
International AIDS Society (IAS) president Prof Dr Adeeba Kamarulzaman noted that the rollout of HIV antiretroviral drugs – which she described as ... View article...
A second major HIV prospect has been put on hold, this time from Gilead Sciences. But unlike the recent halt on Merck's drug islatravir, ... View article...
Under a new agreement, licenced manufacturers will be able to supply generic versions of ViiV's long-acting cabotegravir HIV pre-exposure ... View article...
Fears about undiagnosed or untreated HIV cases in Black and Latino communities are rising after the pandemic led to plummeting numbers of tests ... View article...